Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of drugs improving insulin resistance for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis.